PCN28 Cost-Effectiveness Analysis of Avelumab for Treatment-Experienced and Treatment-Naïve Patients with Metastatic Merkel CELL Carcinoma in Taiwan

Abstract

Authors

W.C. Chang K. Kuo R. Palencia J. Hsu A.Y. Lin C. Goh H.C. Chang P. Chou

Full Text Cite This Article
Back to Volume 22, Supplemental S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×